N-Phenethyl-14-ethoxymetopon

From WikiMD's WELLNESSPEDIA

N-Phenethyl-14-ethoxymetopon is a potent opioid analgesic drug that is structurally related to metopon and the morphinan family. It was developed by a team at the University of Alberta in the late 1990s.

Chemistry[edit]

N-Phenethyl-14-ethoxymetopon is a derivative of metopon, which itself is a derivative of hydromorphone. It is synthesized by replacing the N-methyl group of metopon with a phenethyl group, and the 14-hydroxy group with an ethoxy group. This modification results in a drug that is approximately 60 times more potent than morphine in its analgesic effects.

Pharmacology[edit]

Like other opioids, N-Phenethyl-14-ethoxymetopon acts on the mu opioid receptor to produce its analgesic effects. It is thought to be a full agonist at this receptor, meaning it can fully activate the receptor to produce its maximum possible response.

Clinical Use[edit]

Despite its potency, N-Phenethyl-14-ethoxymetopon is not currently used in clinical practice. Its development was primarily for research purposes, to better understand the structure-activity relationships of opioid drugs. However, its high potency and long duration of action suggest that it could potentially be useful in the treatment of severe chronic pain.

See Also[edit]

References[edit]

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


N-Phenethyl-14-ethoxymetopon[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.